相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
Peter G. K. Clark et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
A Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3)
H. Uemit Kaniskan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Small molecule chemical probes of microRNA function
Sai Pradeep Velagapudi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Emerging approaches for histone deacetylase inhibitor drug discovery
Clemens Zwergel et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
Hannah Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A germline mutation in PBRM1 predisposes to renal cell carcinoma
Patrick R. Benusiglio et al.
JOURNAL OF MEDICAL GENETICS (2015)
Pharmacological targeting of the Wdr5-MLL interaction in C/EBP alpha N-terminal leukemia
Florian Grebien et al.
NATURE CHEMICAL BIOLOGY (2015)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
MOZ and BMI1 play opposing roles during Hox gene activation in ES cells and in body segment identity specification in vivo
Bilal N. Sheikh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Ariane Hammitzsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
Lei-lei Fu et al.
ONCOTARGET (2015)
The Lysine Acetyltransferase Activator Brpf1 Governs Dentate Gyrus Development through Neural Stem Cells and Progenitors
Linya You et al.
PLOS GENETICS (2015)
Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries
Patompon Wongtrakoongate
WORLD JOURNAL OF STEM CELLS (2015)
Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions
Michael Brand et al.
ACS CHEMICAL BIOLOGY (2015)
Inhibition of H3K27me3-Specific Histone Demethylases JMJD3 and UTX Blocks Reactivation of Herpes Simplex Virus 1 in Trigeminal Ganglion Neurons
Harald G. P. Messer et al.
JOURNAL OF VIROLOGY (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
The Role of BAF (mSWI/SNF) Complexes in Mammalian Neural Development
Esther Y. Son et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2014)
The bromodomain: From epigenome reader to druggable target
Roberto Sanchez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
Katherine C. Helming et al.
CANCER CELL (2014)
Bromodomains and Their Pharmacological Inhibitors
Daniel Gallenkamp et al.
CHEMMEDCHEM (2014)
The methyltransferase G9a regulates HoxA9-dependent transcription in AML
Bernhard Lehnertz et al.
GENES & DEVELOPMENT (2014)
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Duncan A. Hay et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
BRD7, a Tumor Suppressor, Interacts with p85α and Regulates PI3K Activity
Yu-Hsin Chiu et al.
MOLECULAR CELL (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Genome-wide localization of small molecules
Lars Anders et al.
NATURE BIOTECHNOLOGY (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Histone core modifications regulating nucleosome structure and dynamics
Peter Tessarz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation
Chandrima Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells
Dalia Barsyte-Lovejoy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A rationale to target the SWI/SNF complex for cancer therapy
Anja F. Hohmann et al.
TRENDS IN GENETICS (2014)
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
Ramzi F. Sweis et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Histone acetylation mediated by Brd1 is crucial for Cd8 gene activation during early thymocyte development
Yuta Mishima et al.
NATURE COMMUNICATIONS (2014)
RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc as a Driver of Pten-Mutant Metastasis
Hyejin Cho et al.
CANCER DISCOVERY (2014)
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Kyle D. Konze et al.
ACS CHEMICAL BIOLOGY (2013)
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
Guillermo Senisterra et al.
BIOCHEMICAL JOURNAL (2013)
Bromo-deaza-SAH: A potent and selective DOT1L inhibitor
Wenyu Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Control of the Hippo Pathway by Set7-Dependent Methylation of Yap
Menno J. Oudhoff et al.
DEVELOPMENTAL CELL (2013)
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP
Feng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration
Saumya Shree Gupta et al.
JOURNAL OF VIROLOGY (2013)
Recruitment of Brd4 to the Human Papillomavirus Type 16 DNA Replication Complex Is Essential for Replication of Viral DNA
Xin Wang et al.
JOURNAL OF VIROLOGY (2013)
EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex
Haruya Ohno et al.
NATURE (2013)
Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain
Lindsey I. James et al.
NATURE CHEMICAL BIOLOGY (2013)
BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1
Helen Jayne Susan Stewart et al.
CANCER MEDICINE (2013)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L
Aravind Basavapathruni et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Epigenetic Chemical Probes
S. Mueller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The bromodomain interaction module
Panagis Filippakopoulos et al.
FEBS LETTERS (2012)
G9a mediates Sharp-1-dependent inhibition of skeletal muscle differentiation
Belinda Mei Tze Ling et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
Laurens Kruidenier et al.
NATURE (2012)
SS18 Together with Animal-Specific Factors Defines Human BAF-Type SWI/SNF Complexes
Evelien Middeljans et al.
PLOS ONE (2012)
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
Sharad K. Verma et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Wenyu Yu et al.
NATURE COMMUNICATIONS (2012)
The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis
Yuta Mishima et al.
BLOOD (2011)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
Bromodomains as therapeutic targets
Susanne Muller et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states
Tim J. Wigle et al.
FEBS LETTERS (2011)
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
Martin Philpott et al.
MOLECULAR BIOSYSTEMS (2011)
The Methyltransferase Set7/9 (Setd7) Is Dispensable for the p53-Mediated DNA Damage Response In Vivo
Stefano Campaner et al.
MOLECULAR CELL (2011)
Getting pharmaceutical R&D back on target
Mark E. Bunnage
NATURE CHEMICAL BIOLOGY (2011)
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Masoud Vedadi et al.
NATURE CHEMICAL BIOLOGY (2011)
Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1)
Xiangyu Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Andrew D. Ferguson et al.
STRUCTURE (2011)
RNA Polymerase II Stalling Promotes Nucleosome Occlusion and pTEFb Recruitment to Drive Immortalization by Epstein-Barr Virus
Richard D. Palermo et al.
PLOS PATHOGENS (2011)
Probing the Probes: Fitness Factors For Small Molecule Tools
Paul Workman et al.
CHEMISTRY & BIOLOGY (2010)
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Louis A. Saddic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
BRD7 is a candidate tumour suppressor gene required for p53 function
Jarno Drost et al.
NATURE CELL BIOLOGY (2010)
The art of the chemical probe
Stephen V. Frye
NATURE CHEMICAL BIOLOGY (2010)
Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+cells
J. Paggetti et al.
ONCOGENE (2010)
The case for open-access chemical biology
Johan Weigelt
EMBO REPORTS (2009)
Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA
Bo Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Open access chemical and clinical probes to support drug discovery
Aled M. Edwards et al.
NATURE CHEMICAL BIOLOGY (2009)
Transcriptional control of the inflammatory response
Ruslan Medzhitov et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity
Kathrin Laue et al.
DEVELOPMENT (2008)
Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha
Luigi Scotto et al.
MOLECULAR CANCER (2008)
Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation
Robert K. McGinty et al.
NATURE (2008)
H3K27 demethylases, at long last
Tomek Swigut et al.
CELL (2007)
The MYST family of histone acetyltransferases and their intimate links to cancer
N. Avvakumov et al.
ONCOGENE (2007)
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase
Stefan Kubicek et al.
MOLECULAR CELL (2007)
Repression of p53 activity by Smyd2-mediated methylation
Jing Huang et al.
NATURE (2006)
Epigenetics A Historical Overview
Robin Holliday
EPIGENETICS (2006)
CBP and p300: HATs for different occasions
E Kalkhoven
BIOCHEMICAL PHARMACOLOGY (2004)
分享论文
